“…Meanwhile, some studies showed a statistical association of upgrades with similar variables. 9,15,17,19,27,30,31,36,43,[45][46][47] In a study by Youk et al, 46 8 (5.0%) of 160 papillomas at US-guided 14-gauge CNB were upgraded to malignancy, and imaging-histologic discordance, patient age (≥50 years), lesion size (≥1 cm), lesion distance from the nipple (≥3 cm), and BI-RADS category were helpful in predicting the possibility of an upgrade to malignancy. Two other studies 43,47 reported that lesions smaller than 1.5 cm had statistically significantly lower upgrade rates.…”